JP2025527657A5 - - Google Patents
Info
- Publication number
- JP2025527657A5 JP2025527657A5 JP2025511446A JP2025511446A JP2025527657A5 JP 2025527657 A5 JP2025527657 A5 JP 2025527657A5 JP 2025511446 A JP2025511446 A JP 2025511446A JP 2025511446 A JP2025511446 A JP 2025511446A JP 2025527657 A5 JP2025527657 A5 JP 2025527657A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- target
- cell population
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2022/073443 | 2022-08-23 | ||
| PCT/EP2022/073443 WO2023025779A1 (en) | 2021-08-25 | 2022-08-23 | Combination of antigen specific t cell receptors and chimeric co-stimulatory receptors |
| PCT/EP2023/058651 WO2024041761A1 (en) | 2022-08-23 | 2023-04-03 | Combination of ny-eso-1 specific t cell receptors and chimeric co-stimulatory receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025527657A JP2025527657A (ja) | 2025-08-22 |
| JP2025527657A5 true JP2025527657A5 (enExample) | 2026-04-09 |
Family
ID=86052345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025511446A Pending JP2025527657A (ja) | 2022-08-23 | 2023-04-03 | Ｎｙ－ｅｓｏ－１特異的ｔ細胞受容体とキメラ共刺激受容体との組み合わせ物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20260055159A1 (enExample) |
| EP (1) | EP4577232A1 (enExample) |
| JP (1) | JP2025527657A (enExample) |
| CN (1) | CN119768178A (enExample) |
| WO (1) | WO2024041761A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025190565A1 (en) * | 2024-03-13 | 2025-09-18 | T-Knife Gmbh | A chimeric programmed cell death protein 1 receptor |
| CN119161418B (zh) * | 2024-08-30 | 2025-11-21 | 天津大学 | 一种结合ny-eso-1抗原的蛋白 |
| CN121159702B (zh) * | 2025-08-31 | 2026-03-20 | 广东工业大学 | 一种重组质粒纳米抗体突变体m1及其制备方法与应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4703004A (en) | 1984-01-24 | 1987-10-27 | Immunex Corporation | Synthesis of protein with an identification peptide |
| US4851341A (en) | 1986-12-19 | 1989-07-25 | Immunex Corporation | Immunoaffinity purification system |
| EP2006376A1 (en) | 2007-06-21 | 2008-12-24 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof |
| EP3433269B1 (en) * | 2016-03-23 | 2023-09-27 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Fusion proteins of pd-1 and 4-1bb |
| US11866731B2 (en) * | 2017-11-10 | 2024-01-09 | Chineo Medical Technology Co., Ltd | Modified immune cells and uses thereof |
| US11738047B2 (en) * | 2017-12-12 | 2023-08-29 | The Trustees Of The University Of Pennsylvania | Genetically modified immune cells targeting NY-ESO-1 and methods of use thereof |
| TWI822726B (zh) * | 2018-02-26 | 2023-11-21 | 德商梅迪基因免疫治療公司 | Ｎｙｅｓｏ ｔ細胞受體 |
| EP4431110A3 (en) * | 2020-01-19 | 2025-01-15 | Chineo Medical Technology Co., Ltd. | Enhanced receptor for improving immune cell function |
-
2023
- 2023-04-03 US US19/105,413 patent/US20260055159A1/en active Pending
- 2023-04-03 CN CN202380061160.4A patent/CN119768178A/zh active Pending
- 2023-04-03 WO PCT/EP2023/058651 patent/WO2024041761A1/en not_active Ceased
- 2023-04-03 JP JP2025511446A patent/JP2025527657A/ja active Pending
- 2023-04-03 EP EP23717456.0A patent/EP4577232A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025527657A5 (enExample) | ||
| JP7720950B2 (ja) | Ｉｌ－１２及びｉｌ－１８へのｉｌ－１５系融合 | |
| JP7554742B2 (ja) | 抗ｔｃｒ抗体分子およびその使用 | |
| US12486326B2 (en) | Anti-TCR antibody molecules and uses thereof | |
| JP2024177479A (ja) | 補体依存性細胞溶解のエフェクター機能の調節のための修飾されたヒトＩｇＭ定常領域 | |
| DE69534528T2 (de) | Mehrstufiger kaskade-erhöhungs-impfstoff | |
| JP2021536249A5 (enExample) | ||
| JP2018532407A5 (enExample) | ||
| JP2019531074A5 (enExample) | ||
| JP2019150066A5 (enExample) | ||
| JP2023552998A5 (enExample) | ||
| US20180355318A1 (en) | Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof | |
| AU2016363025A1 (en) | Modified chimeric receptors and related compositions and methods | |
| JP2018520679A5 (enExample) | ||
| RU2017111298A (ru) | Т-КЛЕТКИ С КОСТИМУЛИРУЮЩИМ ХИМЕРНЫМ АНТИГЕННЫМ РЕЦЕПТОРОМ, НАЦЕЛЕННЫЕ НА IL13Rα2 | |
| CA2963798A1 (en) | Humanized anti-ox40 antibodies and uses thereof | |
| JP2025500522A (ja) | Ｔｃｒに結合する多機能性分子およびその使用 | |
| JP2020501512A5 (enExample) | ||
| JP2024527879A5 (enExample) | ||
| JP2024528981A5 (enExample) | ||
| JP2020512284A5 (enExample) | ||
| JP2024156878A5 (enExample) | ||
| WO2024254611A2 (en) | Multispecific molecules binding to tcr and uses thereof | |
| KR20210144740A (ko) | T 세포 수용체 및 이의 사용 방법 | |
| KR20210144737A (ko) | T 세포 수용체 및 이의 사용 방법 |